Essent debuts new stem cells for research

By The Science Advisory Board staff writers

Nonprofit biotechnology firm Essent Biologics has launched human mesenchymal stem cells (hMSCs) for applications in regenerative medicine and biopharmaceutical and cell therapy research.

The stem cells are recovered, expanded, and cryopreserved without the use of antibiotics or animal products. To ensure potency, each vial contains more than 1 million cells at thaw and a passage level of P0 or P1.

Full donor information and a source biopsy are also available with each stem cell order.

Essent Biologics has launched human mesenchymal stem cells for regenerative medicine and biopharmaceutical and cell therapy research.
Essent Biologics has launched human mesenchymal stem cells for regenerative medicine, biopharmaceutical, and cell therapy research. Image courtesy of Essent Biologics.

Copyright © 2021 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?